Annual SG&A
$7.11 M
-$5.34 M-42.87%
31 December 2023
Summary:
GT Biopharma annual selling, general & administrative expenses is currently $7.11 million, with the most recent change of -$5.34 million (-42.87%) on 31 December 2023. During the last 3 years, it has risen by +$831.00 thousand (+13.23%). GTBP annual SG&A is now -94.71% below its all-time high of $134.50 million, reached on 31 December 2017.GTBP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.30 M
+$175.00 K+8.25%
30 September 2024
Summary:
GT Biopharma quarterly selling, general & administrative expenses is currently $2.30 million, with the most recent change of +$175.00 thousand (+8.25%) on 30 September 2024. Over the past year, it has increased by +$539.00 thousand (+30.66%). GTBP quarterly SG&A is now -98.18% below its all-time high of $126.33 million, reached on 30 September 2017.GTBP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.75 B
-$12.35 M-0.45%
30 September 2024
Summary:
GT Biopharma TTM selling, general & administrative expenses is currently -$2.75 billion, with the most recent change of -$12.35 million (-0.45%) on 30 September 2024. Over the past year, it has dropped by -$2.75 billion (-33444.13%). GTBP TTM SG&A is now -25804.61% below its all-time high of $137.66 million, reached on 30 June 2018.GTBP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.9% | +30.7% | -10000.0% |
| 3 y3 years | +13.2% | -53.6% | -7324.5% |
| 5 y5 years | -43.1% | -35.9% | -10000.0% |
GTBP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -85.2% | +13.2% | -80.7% | +50.5% | -10.4% | at low |
| 5 y | 5 years | -85.2% | +13.2% | -91.6% | +207.9% | -26.9% | at low |
| alltime | all time | -94.7% | +660.4% | -98.2% | +1139.4% | <-9999.0% | at low |
GT Biopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.30 M(+8.2%) | $8.54 M(+6.7%) |
| June 2024 | - | $2.12 M(-8.3%) | $8.01 M(+8.0%) |
| Mar 2024 | - | $2.31 M(+27.8%) | $7.41 M(+4.2%) |
| Dec 2023 | $7.11 M(-42.9%) | $1.81 M(+3.0%) | $7.11 M(-13.7%) |
| Sept 2023 | - | $1.76 M(+15.2%) | $8.23 M(-23.4%) |
| June 2023 | - | $1.53 M(-24.3%) | $10.76 M(-3.1%) |
| Mar 2023 | - | $2.02 M(-31.4%) | $11.11 M(-10.8%) |
| Dec 2022 | $12.45 M(-74.0%) | $2.94 M(-31.4%) | $12.45 M(-41.8%) |
| Sept 2022 | - | $4.28 M(+128.3%) | $21.38 M(-3.0%) |
| June 2022 | - | $1.88 M(-44.1%) | $22.05 M(-7.8%) |
| Mar 2022 | - | $3.35 M(-71.7%) | $23.92 M(-50.1%) |
| Dec 2021 | $47.92 M(+663.2%) | $11.87 M(+140.1%) | $47.92 M(+26.1%) |
| Sept 2021 | - | $4.95 M(+32.2%) | $38.01 M(+8.3%) |
| June 2021 | - | $3.74 M(-86.3%) | $35.09 M(+6.7%) |
| Mar 2021 | - | $27.36 M(+1297.4%) | $32.90 M(+423.9%) |
| Dec 2020 | $6.28 M(-35.9%) | $1.96 M(-3.5%) | $6.28 M(+21.2%) |
| Sept 2020 | - | $2.03 M(+31.2%) | $5.18 M(-23.1%) |
| June 2020 | - | $1.55 M(+107.2%) | $6.74 M(-7.9%) |
| Mar 2020 | - | $746.00 K(-13.1%) | $7.31 M(-25.3%) |
| Dec 2019 | $9.79 M(-21.6%) | $858.00 K(-76.1%) | $9.79 M(-9.3%) |
| Sept 2019 | - | $3.58 M(+68.7%) | $10.79 M(-11.8%) |
| June 2019 | - | $2.13 M(-34.0%) | $12.24 M(+1.8%) |
| Mar 2019 | - | $3.22 M(+73.3%) | $12.02 M(-3.7%) |
| Dec 2018 | $12.49 M(-90.7%) | $1.86 M(-63.1%) | $12.49 M(-23.7%) |
| Sept 2018 | - | $5.04 M(+164.2%) | $16.36 M(-88.1%) |
| June 2018 | - | $1.91 M(-48.3%) | $137.66 M(+0.6%) |
| Mar 2018 | - | $3.69 M(-35.7%) | $136.79 M(+1.7%) |
| Dec 2017 | $134.50 M(+1501.4%) | $5.73 M(-95.5%) | $134.50 M(+4.0%) |
| Sept 2017 | - | $126.33 M(>+9900.0%) | $129.34 M(+2345.0%) |
| June 2017 | - | $1.04 M(-25.1%) | $5.29 M(-13.5%) |
| Mar 2017 | - | $1.39 M(+143.7%) | $6.12 M(-27.2%) |
| Dec 2016 | $8.40 M(+5.6%) | $572.00 K(-74.9%) | $8.40 M(-17.7%) |
| Sept 2016 | - | $2.28 M(+21.9%) | $10.21 M(-2.6%) |
| June 2016 | - | $1.87 M(-49.1%) | $10.48 M(+4.2%) |
| Mar 2016 | - | $3.68 M(+54.3%) | $10.06 M(+26.5%) |
| Dec 2015 | $7.95 M(+231.4%) | $2.38 M(-6.6%) | $7.95 M(+10.3%) |
| Sept 2015 | - | $2.55 M(+75.9%) | $7.21 M(+38.5%) |
| June 2015 | - | $1.45 M(-7.5%) | $5.21 M(+34.6%) |
| Mar 2015 | - | $1.57 M(-4.4%) | $3.87 M(+61.1%) |
| Dec 2014 | $2.40 M(+156.7%) | $1.64 M(+199.8%) | $2.40 M(+137.4%) |
| Sept 2014 | - | $547.00 K(+388.4%) | $1.01 M(+52.3%) |
| June 2014 | - | $112.00 K(+10.9%) | $664.00 K(-0.9%) |
| Mar 2014 | - | $101.00 K(-59.8%) | $670.00 K(-28.3%) |
| Dec 2013 | $935.00 K(-75.1%) | $251.00 K(+25.5%) | $935.00 K(-40.9%) |
| Sept 2013 | - | $200.00 K(+69.5%) | $1.58 M(-43.9%) |
| June 2013 | - | $118.00 K(-67.8%) | $2.82 M(-24.5%) |
| Mar 2013 | - | $366.00 K(-59.2%) | $3.73 M(-0.8%) |
| Dec 2012 | $3.76 M(-3.3%) | $897.00 K(-37.6%) | $3.76 M(-4.7%) |
| Sept 2012 | - | $1.44 M(+39.5%) | $3.95 M(+29.6%) |
| June 2012 | - | $1.03 M(+159.7%) | $3.05 M(+24.1%) |
| Mar 2012 | - | $397.00 K(-63.3%) | $2.45 M(-36.9%) |
| Dec 2011 | $3.89 M(+71.8%) | $1.08 M(+102.4%) | $3.89 M(+19.3%) |
| Sept 2011 | - | $535.00 K(+21.9%) | $3.26 M(-1.6%) |
| June 2011 | - | $439.00 K(-76.0%) | $3.31 M(+4.5%) |
| Mar 2011 | - | $1.83 M(+303.5%) | $3.17 M(+40.1%) |
| Dec 2010 | $2.26 M(+96.2%) | $454.00 K(-22.8%) | $2.26 M(-9.8%) |
| Sept 2010 | - | $588.00 K(+98.0%) | $2.51 M(+25.1%) |
| June 2010 | - | $297.00 K(-67.9%) | $2.01 M(+3.4%) |
| Mar 2010 | - | $925.00 K(+32.0%) | $1.94 M(+68.1%) |
| Dec 2009 | $1.15 M(-17.6%) | $701.00 K(+734.5%) | $1.16 M(+57.1%) |
| Sept 2009 | - | $84.00 K(-63.6%) | $735.00 K(-28.9%) |
| June 2009 | - | $231.00 K(+66.2%) | $1.03 M(+5.4%) |
| Mar 2009 | - | $139.00 K(-50.5%) | $981.00 K(-30.0%) |
| Dec 2008 | $1.40 M(-51.1%) | $281.00 K(-26.6%) | $1.40 M(-20.1%) |
| Sept 2008 | - | $383.00 K(+115.2%) | $1.75 M(-21.1%) |
| June 2008 | - | $178.00 K(-68.2%) | $2.22 M(-10.6%) |
| Mar 2008 | - | $559.00 K(-11.7%) | $2.48 M(-13.3%) |
| Dec 2007 | $2.87 M | $633.00 K(-25.7%) | $2.87 M(-28.9%) |
| Sept 2007 | - | $852.00 K(+93.2%) | $4.03 M(-2.4%) |
| June 2007 | - | $441.00 K(-53.1%) | $4.13 M(-8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $941.00 K(-47.7%) | $4.53 M(-2.6%) |
| Dec 2006 | $4.65 M(+98.7%) | $1.80 M(+88.9%) | $4.65 M(+27.7%) |
| Sept 2006 | - | $953.00 K(+13.9%) | $3.65 M(+15.3%) |
| June 2006 | - | $837.00 K(-21.3%) | $3.16 M(+10.2%) |
| Mar 2006 | - | $1.06 M(+34.5%) | $2.87 M(+22.5%) |
| Dec 2005 | $2.34 M(+15.6%) | $791.00 K(+68.3%) | $2.34 M(+76.1%) |
| Sept 2005 | - | $470.00 K(-13.8%) | $1.33 M(-1.1%) |
| June 2005 | - | $545.00 K(+1.7%) | $1.34 M(-6.3%) |
| Mar 2005 | - | $536.00 K(-342.5%) | $1.44 M(-4.3%) |
| Dec 2004 | $2.03 M(+22.9%) | -$221.00 K(-145.6%) | $1.50 M(-32.6%) |
| Sept 2004 | - | $485.00 K(-23.7%) | $2.23 M(+6.0%) |
| June 2004 | - | $636.00 K(+5.8%) | $2.10 M(+12.0%) |
| Mar 2004 | - | $601.00 K(+19.2%) | $1.88 M(+13.8%) |
| Dec 2003 | $1.65 M(+31.0%) | $504.00 K(+40.4%) | $1.65 M(+19.2%) |
| Sept 2003 | - | $359.00 K(-12.7%) | $1.38 M(+2.4%) |
| June 2003 | - | $411.00 K(+9.9%) | $1.35 M(+9.5%) |
| Mar 2003 | - | $374.00 K(+56.5%) | $1.23 M(-1.9%) |
| Dec 2002 | $1.26 M(-45.0%) | $239.00 K(-26.9%) | $1.26 M(+5.0%) |
| Sept 2002 | - | $327.00 K(+11.2%) | $1.20 M(-5.3%) |
| June 2002 | - | $294.00 K(-26.1%) | $1.26 M(-27.8%) |
| Mar 2002 | - | $398.00 K(+122.3%) | $1.75 M(-23.1%) |
| Dec 2001 | $2.29 M(-30.6%) | $179.00 K(-54.6%) | $2.28 M(-23.0%) |
| Sept 2001 | - | $394.00 K(-49.6%) | $2.96 M(-18.6%) |
| June 2001 | - | $782.00 K(-15.5%) | $3.64 M(+4.0%) |
| Mar 2001 | - | $925.00 K(+7.4%) | $3.50 M(+6.2%) |
| Dec 2000 | $3.30 M(+0.4%) | $861.00 K(-19.7%) | $3.30 M(+2.4%) |
| Sept 2000 | - | $1.07 M(+67.0%) | $3.22 M(+9.2%) |
| June 2000 | - | $642.00 K(-11.1%) | $2.95 M(-5.1%) |
| Mar 2000 | - | $722.00 K(-8.0%) | $3.11 M(-5.4%) |
| Dec 1999 | $3.29 M(-8.8%) | $785.00 K(-1.9%) | $3.29 M(-3.4%) |
| Sept 1999 | - | $800.00 K(0.0%) | $3.40 M(-8.1%) |
| June 1999 | - | $800.00 K(-11.1%) | $3.70 M(0.0%) |
| Mar 1999 | - | $900.00 K(0.0%) | $3.70 M(-2.6%) |
| Dec 1998 | $3.60 M(+38.5%) | $900.00 K(-18.2%) | $3.80 M(+8.6%) |
| Sept 1998 | - | $1.10 M(+37.5%) | $3.50 M(+12.9%) |
| June 1998 | - | $800.00 K(-20.0%) | $3.10 M(+3.3%) |
| Mar 1998 | - | $1.00 M(+66.7%) | $3.00 M(+15.4%) |
| Dec 1997 | $2.60 M(-66.2%) | $600.00 K(-14.3%) | $2.60 M(-65.3%) |
| Sept 1997 | - | $700.00 K(0.0%) | $7.50 M(+1.4%) |
| June 1997 | - | $700.00 K(+16.7%) | $7.40 M(-2.6%) |
| Mar 1997 | - | $600.00 K(-89.1%) | $7.60 M(-1.3%) |
| Dec 1996 | $7.70 M(+133.3%) | $5.50 M(+816.7%) | $7.70 M(+140.6%) |
| Sept 1996 | - | $600.00 K(-33.3%) | $3.20 M(-5.9%) |
| June 1996 | - | $900.00 K(+28.6%) | $3.40 M(+3.0%) |
| Mar 1996 | - | $700.00 K(-30.0%) | $3.30 M(0.0%) |
| Dec 1995 | $3.30 M(+94.1%) | $1.00 M(+25.0%) | $3.30 M(+10.0%) |
| Sept 1995 | - | $800.00 K(0.0%) | $3.00 M(+11.1%) |
| June 1995 | - | $800.00 K(+14.3%) | $2.70 M(+28.6%) |
| Mar 1995 | - | $700.00 K(0.0%) | $2.10 M(+23.5%) |
| Dec 1994 | $1.70 M(-50.0%) | $700.00 K(+40.0%) | $1.70 M(+6.3%) |
| Sept 1994 | - | $500.00 K(+150.0%) | $1.60 M(-20.0%) |
| June 1994 | - | $200.00 K(-33.3%) | $2.00 M(-39.4%) |
| Mar 1994 | - | $300.00 K(-50.0%) | $3.30 M(-2.9%) |
| Dec 1993 | $3.40 M(+61.9%) | $600.00 K(-33.3%) | $3.40 M(+6.3%) |
| Sept 1993 | - | $900.00 K(-40.0%) | $3.20 M(+10.3%) |
| June 1993 | - | $1.50 M(+275.0%) | $2.90 M(+52.6%) |
| Mar 1993 | - | $400.00 K(0.0%) | $1.90 M(-5.0%) |
| Dec 1992 | $2.10 M(-4.5%) | $400.00 K(-33.3%) | $2.00 M(-4.8%) |
| Sept 1992 | - | $600.00 K(+20.0%) | $2.10 M(0.0%) |
| June 1992 | - | $500.00 K(0.0%) | $2.10 M(+31.3%) |
| Mar 1992 | - | $500.00 K(0.0%) | $1.60 M(+45.5%) |
| Dec 1991 | $2.20 M(-8.3%) | $500.00 K(-16.7%) | $1.10 M(+83.3%) |
| Sept 1991 | - | $600.00 K | $600.00 K |
| Dec 1990 | $2.40 M(-4.0%) | - | - |
| Dec 1989 | $2.50 M(+19.0%) | - | - |
| Dec 1988 | $2.10 M(+31.3%) | - | - |
| Dec 1987 | $1.60 M(-36.0%) | - | - |
| Dec 1986 | $2.50 M(+8.7%) | - | - |
| Dec 1985 | $2.30 M(+15.0%) | - | - |
| Dec 1984 | $2.00 M(+5.3%) | - | - |
| Feb 1984 | $1.90 M | - | - |
FAQ
- What is GT Biopharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for GT Biopharma?
- What is GT Biopharma annual SG&A year-on-year change?
- What is GT Biopharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for GT Biopharma?
- What is GT Biopharma quarterly SG&A year-on-year change?
- What is GT Biopharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for GT Biopharma?
- What is GT Biopharma TTM SG&A year-on-year change?
What is GT Biopharma annual selling, general & administrative expenses?
The current annual SG&A of GTBP is $7.11 M
What is the all time high annual SG&A for GT Biopharma?
GT Biopharma all-time high annual selling, general & administrative expenses is $134.50 M
What is GT Biopharma annual SG&A year-on-year change?
Over the past year, GTBP annual selling, general & administrative expenses has changed by -$5.34 M (-42.87%)
What is GT Biopharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of GTBP is $2.30 M
What is the all time high quarterly SG&A for GT Biopharma?
GT Biopharma all-time high quarterly selling, general & administrative expenses is $126.33 M
What is GT Biopharma quarterly SG&A year-on-year change?
Over the past year, GTBP quarterly selling, general & administrative expenses has changed by +$539.00 K (+30.66%)
What is GT Biopharma TTM selling, general & administrative expenses?
The current TTM SG&A of GTBP is -$2.75 B
What is the all time high TTM SG&A for GT Biopharma?
GT Biopharma all-time high TTM selling, general & administrative expenses is $137.66 M
What is GT Biopharma TTM SG&A year-on-year change?
Over the past year, GTBP TTM selling, general & administrative expenses has changed by -$2.75 B (-33444.13%)